Patients with asymptomatic disease often do not require treatment. Spontaneous remission is common for mild disease. For patients with more extensive manifestations, treatment is tailored to the affected systems. Glucocorticoids are typically the first line of treatment, and maintenance doses are sometimes required for years. For refractory cases, DMARDs are sometimes employed. See also BCSC Section 9, Uveitis and Ocular Inflammation.
Excerpted from BCSC 2020-2021 series: Section 1 - Update on General Medicine. For more information and to purchase the entire series, please visit https://www.aao.org/bcsc.